Patent Assignment
Reel/Frame 060970/0188
Assignment of Assignor's Interest
Recorded: 2022-09-01
Pages: 4
Assignors
JONES, KYLE
Executed: 2019-08-30
CRAGO, WILLIAM
Executed: 2019-08-22
SANABRIA, ANGELICA
Executed: 2019-09-03
HOLLANDS, ANDREW
Executed: 2019-08-23
GANO, JACOB
Executed: 2019-08-27
MA, MILTON
Executed: 2019-08-27
TIMMER, JOHN C.
Executed: 2019-08-26
ECKELMAN, BRENDAN P.
Executed: 2019-08-26
Assignee
INHIBRX, INC.
11025 N. TORREY PINES ROAD, SUITE 200, LA JOLLA, CALIFORNIA, 92037
Covered Property
(1)
CD33 Targeted Immunotherapies
Related Assignments
(6)
Other recorded transfers of the patent in this record — the chain of ownership.
Intellectual Property Security Agreement
Feb 28, 2022
From: INHIBRX, INC.
To: OXFORD FINANCE LLC
Reel/Frame 059262/0780 →
Assignment of Assignor's Interest
Mar 7, 2022
From: JARJOUR, JORDAN; POGSON, MARK; LEUNG, WAI-HANG
To: 2SEVENTY BIO, INC.
Reel/Frame 059181/0749 →
Assignment of Assignor's Interest
Apr 22, 2024
From: 2SEVENTY BIO, INC.
To: REGENERON PHARMACEUTICALS, INC.
Reel/Frame 067184/0147 →
Release of Security Interest
Jun 3, 2024
From: OXFORD FINANCE LLC, AS COLLATERAL AGENT
To: INHIBRX, INC.
Reel/Frame 067606/0247 →
Assignment of Assignor's Interest
Jun 10, 2024
From: INHIBRX, INC.
To: INHIBRX BIOSCIENCES, INC.
Reel/Frame 067679/0338 →
Security Interest
Jan 14, 2025
From: INHIBRX BIOSCIENCES, INC.
To: OXFORD FINANCE LLC; OXFORD FINANCE LLC
Reel/Frame 069894/0045 →